Company: U.S. Food and Drug Administration
Job title: Director of Controlled Substances Staff
Dr. Chiapperino is the Director of the Controlled Substance Staff (CSS), a group with expertise in the assessment of the abuse potential of drugs. He has worked extensively on FDA policy and regulatory issues involving cannabis and related substances and, prior to CSS, was with CDER’s Division of Anesthesia, Analgesia, and Addiction Products gaining regulatory experience concerning opioids analgesics and drugs indicated for the treatment of substance use disorders. He received his PhD in organic chemistry from the University of Maryland in 2000 and did post-doctoral research with the National Institute of Diabetes and Digestive and Kidney Diseases before beginning his career at FDA in 2002.
FDA Regulatory Roles Concerning Cannabis and New Drug Research 8:30 am
The presentation will discuss FDA regulatory roles for cannabis under both the Food, Drug & Cosmetic Act and the Controlled Substances Act Under FDCA, FDA provides regulatory oversight, and scientific and regulatory support, for research conducted under an IND investigating potential therapeutic uses of cannabis Under the CSA, FDA assists DEA with review and DEA…Read more
day: Day One